HomeProductsBioactive CompoundsTGF-beta/Smad PathwayPKCEnzastaurin
Chemical structure of CAS 170364-57-5

Enzastaurin

In Stock•Starting at $23 for 5 mg•Purity ≥ 98%
CAS No.170364-57-5
MDL No.N/A
MFC32H29N5O2
MW515.60
InChI KeyAXRCEOKUDYDWLF-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mg98%$23In Stock
10 mg98%$26In Stock
50 mg98%$68In Stock
100 mg98%$128In Stock
250 mg98%$234In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

3-(1-methyl-3-indolyl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-3-indolyl]pyrrole-2,5-dione is an indole and a maleimide.

CAS No.170364-57-5
Product NameEnzastaurin
IrritantIrritant
Signal Word:Warning
HCode:H302-H413
PCode:P264-P270-P273-P301+P317-P330-P501

Related Articles

Studies related to this compound and its mechanism of action

The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway.

The Journal of investigative dermatology • Vol. 126, Issue 7 • 2006
PMID: 16645590DOI: 10.1038/sj.jid.5700322

Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 12, Issue 11 Pt 1 • 2006
PMID: 16740765DOI: 10.1158/1078-0432.CCR-05-2231

American Association for Cancer Research--97th annual meeting.

IDrugs : the investigational drugs journal • Vol. 9, Issue 6 • 2006
PMID: 16752309

Perspectives in central nervous system malignancies.

IDrugs : the investigational drugs journal • Vol. 9, Issue 6 • 2006
PMID: 16752310

Documentation

Similar Products